Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Martin Bakht"'
Autor:
Nicholas J. Brady, Alyssa M. Bagadion, Richa Singh, Vincenza Conteduca, Lucie Van Emmenis, Elisa Arceci, Hubert Pakula, Ryan Carelli, Francesca Khani, Martin Bakht, Michael Sigouros, Rohan Bareja, Andrea Sboner, Olivier Elemento, Scott Tagawa, David M. Nanus, Massimo Loda, Himisha Beltran, Brian Robinson, David S. Rickman
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
The heterogeneity of tumor evolution from AR-positive, adenocarcinoma to AR-negative, neuroendocrine prostate cancer (NEPC) is not fully characterized. Here the authors generate a mouse model to show that Rb1 loss and MYCN overexpression accelerates
Externí odkaz:
https://doaj.org/article/02a3612e2f2a462990758033d59bb602
Autor:
Haoyan Li, Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin Bakht, Wei Shi, Chenling Meng, Jie Zhang, Kaitlyn Tremble, Xin Liang, Jian H. Song, Xu Feng, Vivien Van, Pingna Deng, Jared K. Burks, Ana Aparicio, Khandan Keyomarsi, Junjie Chen, Yue Lu, Himisha Beltran, Di Zhao
Publikováno v:
Cancer Res
Clinical studies have shown that subsets of patients with cancer achieve a significant benefit from Aurora kinase inhibitors, suggesting an urgent need to identify biomarkers for predicting drug response. Chromodomain helicase DNA binding protein 1 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce0d85c5fa6382b34e279e78a8319bfe
https://doi.org/10.1158/0008-5472.can-22-0631
https://doi.org/10.1158/0008-5472.can-22-0631
Autor:
Di Zhao, Himisha Beltran, Yue Lu, Junjie Chen, Khandan Keyomarsi, Ana Aparicio, Jared K. Burks, Pingna Deng, Vivien Van, Xu Feng, Jian H. Song, Xin Liang, Kaitlyn Tremble, Jie Zhang, Chenling Meng, Wei Shi, Martin Bakht, Varadha Balaji Venkadakrishnan, Kevin Lin, Yin Wang, Haoyan Li
Supplementary Figure from CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0964977c9508d917bc50aa8ec22ec725
https://doi.org/10.1158/0008-5472.22432364.v1
https://doi.org/10.1158/0008-5472.22432364.v1
Autor:
Di Zhao, Himisha Beltran, Yue Lu, Junjie Chen, Khandan Keyomarsi, Ana Aparicio, Jared K. Burks, Pingna Deng, Vivien Van, Xu Feng, Jian H. Song, Xin Liang, Kaitlyn Tremble, Jie Zhang, Chenling Meng, Wei Shi, Martin Bakht, Varadha Balaji Venkadakrishnan, Kevin Lin, Yin Wang, Haoyan Li
Clinical studies have shown that subsets of patients with cancer achieve a significant benefit from Aurora kinase inhibitors, suggesting an urgent need to identify biomarkers for predicting drug response. Chromodomain helicase DNA binding protein 1 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdd1c7363b3845814bc6a1c73e08858e
https://doi.org/10.1158/0008-5472.c.6514121.v1
https://doi.org/10.1158/0008-5472.c.6514121.v1
Autor:
Di Zhao, Himisha Beltran, Yue Lu, Junjie Chen, Khandan Keyomarsi, Ana Aparicio, Jared K. Burks, Pingna Deng, Vivien Van, Xu Feng, Jian H. Song, Xin Liang, Kaitlyn Tremble, Jie Zhang, Chenling Meng, Wei Shi, Martin Bakht, Varadha Balaji Venkadakrishnan, Kevin Lin, Yin Wang, Haoyan Li
Supplementary Data from CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52053dfb7c01458e37585f99f5a33665
https://doi.org/10.1158/0008-5472.22432370.v1
https://doi.org/10.1158/0008-5472.22432370.v1
Autor:
Di Zhao, Himisha Beltran, Yue Lu, Junjie Chen, Khandan Keyomarsi, Ana Aparicio, Jared K. Burks, Pingna Deng, Vivien Van, Xu Feng, Jian H. Song, Xin Liang, Kaitlyn Tremble, Jie Zhang, Chenling Meng, Wei Shi, Martin Bakht, Varadha Balaji Venkadakrishnan, Kevin Lin, Yin Wang, Haoyan Li
Supplementary Table from CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12588cb4c48f96721ee0edfefc430f58
https://doi.org/10.1158/0008-5472.22432355
https://doi.org/10.1158/0008-5472.22432355
Autor:
Haoyan Li, Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin Bakht, Kaitlyn Tremble, Yue Lu, Himisha Beltran, Di Zhao
Publikováno v:
Cancer Research. 82:B022-B022
Clinical studies have shown that subsets of cancer patients achieve a significant benefit from Aurora kinase inhibitors, suggesting an urgent need to identify biomarkers for predicting drug response. Chromodomain-helicase-DNA-binding protein 1 (CHD1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3f43614d3d45d3ae764b087ba4ceb1b
https://doi.org/10.1158/1538-7445.cancepi22-b022
https://doi.org/10.1158/1538-7445.cancepi22-b022
Autor:
Martin Bakht, Lucie Van Emmenis, Massimo Loda, Nicholas J. Brady, David M. Nanus, Hubert Pakula, Elisa Arceci, David S. Rickman, Brian D. Robinson, Vincenza Conteduca, Richa Singh, Olivier Elemento, Rohan Bareja, Michael Sigouros, Himisha Beltran, Scott T. Tagawa, Ryan Carelli, Francesca Khani, Alyssa M. Bagadion, Andrea Sboner
Publikováno v:
Nature Communications
Università degli studi di Foggia-IRIS
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Università degli studi di Foggia-IRIS
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance to such therapies frequently ensues. A significant subset of patients with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c409a261f61cd0cc2a6eda3b899c1f
https://doi.org/10.1038/s41467-021-23780-y
https://doi.org/10.1038/s41467-021-23780-y
Autor:
Albert Font, David Olmos, Martin Bakht, Sara Bystrup, José Francisco Suárez, Alberto Indacochea, Carme Sole-Blanch, Eva Martinez-Balibrea, Luis Palomero, Alvaro Aytes, Natalia Jiménez, Himisha Beltran, Mercedes Marín-Aguilera, Elena Castro, Vicenç Ruiz de Porras, Josep M. Piulats, Oscar Buisan, Juan Carlos Pardo, Begoña Mellado, Xieng C. Wang, Vincenza Conteduca
Publikováno v:
Università degli studi di Foggia-IRIS
European Urology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de la UB
Universidad de Barcelona
European Urology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Background: Taxanes are the most active chemotherapy agents in metastatic castration-resistant prostate cancer (mCRPC) patients; yet, resistance occurs almost invariably, representing an important clinical challenge. Taxane-platinum combinations have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351476a91e1a705af71b18427a335885
http://hdl.handle.net/2445/178257
http://hdl.handle.net/2445/178257
Autor:
Martin Bakht, John Hayward, Farsheed Shahbazi-Raz, Daniel Meister, Adam Pillon, Mathew Stover, Adam Tronchin, Lavleen Mader, Bre-Anne Fifield, Sheng-Yu Ku, Gi Jeong Cheon, Keon Wook Kang, Yuzhuo Wang, Xuesen Dong, Himisha Beltran, Lisa Porter, John F. Trant
Prostate-specific membrane antigen (PSMA) is highly overexpressed in most prostate cancers and is clinically visualized using PSMA-specific probes incorporating Glutamate-Ureido-Lysine (GUL). PSMA is effectively absent from certain high-mortality, tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442c56e1f98cb2c2011b54b105ccfcc2
https://doi.org/10.26434/chemrxiv.13064186.v2
https://doi.org/10.26434/chemrxiv.13064186.v2